Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration
- PMID: 22248882
- DOI: 10.1016/j.ejps.2012.01.002
Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration
Abstract
Poly(D,L-lactide-co-glycolide) nanoparticles (PLGA-NP) have been extensively used as a drug delivery system for proteins and peptides. However, their negative surface charge decreases bioavailability under oral administration. Recently, cationically modified PLGA-NP has been introduced as novel carriers for oral delivery. The characteristics of the nanoparticles, such as particle size, surface charge, and bioadhesion are considered the most significant determinants of the effect of these nanoparticles both in vitro and in vivo. Our aim was to introduce and evaluate the physiochemical characteristics, bioadhesion, and biological activity of positively charged chitosan-coated PLGA-NP (CS-PLGA-NP), using insulin as a model drug. Results were compared to those of common negatively charged PLGA-NP and the in vitro cytotoxicity of the two types of nanoparticles was examined. These results indicate that both CS-PLGA-NP and PLGA-NP had a narrow size distribution, averaging less than 150 nm. CS-PLGA-NP was positively charged (+43.1 ± 0.3 mV), exhibiting the cationic nature of chitosan, whereas PLGA-NP showed a negative surface charge (-1.72 ± 0.2 mV). CS-PLGA-NP exhibited stronger bioadhesive potency than PLGA-NP and much greater relative pharmacological availability with regard to orally delivered insulin. In addition, an evaluation of cytotoxicity by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay showed no increase in toxicity in either kind of nanoparticle during the formulation process. The study proves that CS-PLGA-NP can be used as a vector in oral drug delivery systems for proteins and peptides due to its positive surface charge and bioadhesive properties.
Copyright © 2012 Elsevier B.V. All rights reserved.
Similar articles
-
Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system.Int J Pharm. 2018 May 5;542(1-2):47-55. doi: 10.1016/j.ijpharm.2018.02.045. Epub 2018 Mar 6. Int J Pharm. 2018. PMID: 29501738
-
N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.ACS Appl Mater Interfaces. 2015 Jul 22;7(28):15430-41. doi: 10.1021/acsami.5b03555. Epub 2015 Jul 9. ACS Appl Mater Interfaces. 2015. PMID: 26111015
-
Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.Biotechnol Adv. 2015 Nov 1;33(6 Pt 3):1342-54. doi: 10.1016/j.biotechadv.2015.02.010. Epub 2015 Feb 26. Biotechnol Adv. 2015. PMID: 25728065 Review.
-
Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.Drug Deliv. 2016;23(3):787-93. doi: 10.3109/10717544.2014.916765. Epub 2014 May 28. Drug Deliv. 2016. PMID: 24870204
-
[Advance in the study of poly(lactide-co-glycolide) nano/microparticles as gene vector].Yao Xue Xue Bao. 2010 Nov;45(11):1346-53. Yao Xue Xue Bao. 2010. PMID: 21361033 Review. Chinese.
Cited by
-
Efficacy of oral insulin nanoparticles for the management of hyperglycemia in a rat model of diabetes induced with streptozotocin.J Med Life. 2024 Feb;17(2):217-225. doi: 10.25122/jml-2023-0355. J Med Life. 2024. PMID: 38813352 Free PMC article.
-
Concept for a Unidirectional Release Mucoadhesive Buccal Tablet for Oral Delivery of Antidiabetic Peptide Drugs Such as Insulin, Glucagon-like Peptide 1 (GLP-1), and their Analogs.Pharmaceutics. 2023 Sep 1;15(9):2265. doi: 10.3390/pharmaceutics15092265. Pharmaceutics. 2023. PMID: 37765234 Free PMC article.
-
Nanocarrier system: An emerging strategy for bioactive peptide delivery.Front Nutr. 2022 Dec 5;9:1050647. doi: 10.3389/fnut.2022.1050647. eCollection 2022. Front Nutr. 2022. PMID: 36545472 Free PMC article. Review.
-
Linear Dextrin as Potential Insulin Delivery System: Effect of Degree of Polymerization on the Physicochemical Properties of Linear Dextrin-Insulin Inclusion Complexes.Polymers (Basel). 2021 Nov 30;13(23):4187. doi: 10.3390/polym13234187. Polymers (Basel). 2021. PMID: 34883690 Free PMC article.
-
Insulin Granule-Loaded MicroPlates for Modulating Blood Glucose Levels in Type-1 Diabetes.ACS Appl Mater Interfaces. 2021 Nov 17;13(45):53618-53629. doi: 10.1021/acsami.1c16768. Epub 2021 Nov 9. ACS Appl Mater Interfaces. 2021. PMID: 34751556 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous